Pipeline
Vaccines in clinical development
MVA-BN WEV
/ Equine Encephalitis
/ Phase 2 ongoing MVA-BN WEV
/ Equine Encephalitis
/ Phase 2 ongoing
MVA-BN WEV is a multi-valent vaccine candidate developed under contracts with the US government to address the unmet medical need for a vaccine against western, eastern and Venezuelan equine encephalitis viruses, which are rare, but potentially deadly viruses transmitted to humans by mosquitos.